Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2023

Jun 8, 2023

5250_mrq_2023-06-08_3ac179f9-8b91-47d5-901d-8ce20994a28a.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ .f{size:612.0pt 792.0pt;margin:50.0pt 25.0pt 50.0pt 25.0pt;}div.f{}table.ar{border-collapse:collapse;border:none}td.an{border:none;padding:0cm .5pt 0cm .5pt}p.as{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:5.0pt; margin-bottom:0cm;margin-left:5.0pt;margin-bottom:.0001pt;text-align:right}span.ap{font-size:9.0pt;line-height:107%;font-family:"Trebuchet MS","sans-serif"}p.at{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:5.0pt; margin-bottom:0cm;margin-left:5.0pt;margin-bottom:.0001pt;text-align:center}p.au{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:5.0pt;margin-bottom: 0cm;margin-left:5.0pt;margin-bottom:.0001pt}span.al{font-family:"Trebuchet MS","sans-serif"}td.aj{border:solid windowtext 1.0pt;border-right: none;padding:0cm .5pt 0cm .5pt} td.ai{border:solid windowtext 1.0pt;padding:0cm .5pt 0cm .5pt}td.ah{border-top:none;border-left:solid windowtext 1.0pt; border-bottom:solid windowtext 1.0pt;border-right:none;padding:0cm .5pt 0cm .5pt}td.ag{border:solid windowtext 1.0pt;border-top: none;padding:0cm .5pt 0cm .5pt}td.af{border:none;border-left:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.ae{border:solid windowtext 1.0pt; border-top:none;padding:0cm .5pt 0cm .5pt}td.ad{width:112.4pt;border:none;padding:0cm .5pt 0cm .5pt}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}td.ac{width:32.55pt;border:none;padding:0cm .5pt 0cm .5pt}td.ab{border:solid windowtext 1.0pt;border-left: none;padding:0cm .5pt 0cm .5pt}td.aa{border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt; border-right:solid windowtext 1.0pt;padding:0cm .5pt 0cm .5pt} td.z{border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm .5pt 0cm .5pt}td.y{border:solid windowtext 1.0pt;border-top:none; padding:0cm .5pt 0cm .5pt}td.x{width:112.4pt;border-top:none;border-left: solid windowtext 1.0pt;border-bottom:solid windowtext 1.0pt;border-right: none;padding:0cm .5pt 0cm .5pt}td.w{width:32.55pt;border:none;border-bottom:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.v{width:112.4pt;border:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.u{width:32.55pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm .5pt 0cm .5pt}td.t{border-top:solid windowtext 1.0pt;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0cm .5pt 0cm .5pt}td.s{width:112.4pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm .5pt 0cm .5pt}td.r{width:32.55pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.q{width:112.4pt;border:solid windowtext 1.0pt; border-bottom:none;padding:0cm .5pt 0cm .5pt} td.p{width:32.55pt;border-top:solid windowtext 1.0pt; border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.o{border-top:solid windowtext 1.0pt;border-left:none; border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm .5pt 0cm .5pt}td.n{width:112.4pt;border-top:none;border-left: solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.m{width:32.55pt;border:none;border-right:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.l{border:none;border-right:solid windowtext 1.0pt; padding:0cm .5pt 0cm .5pt}td.k{border-top:solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-bottom:none;border-right:none;padding:0cm .5pt 0cm .5pt}td.j{border:solid windowtext 1.0pt;border-bottom: none;padding:0cm .5pt 0cm .5pt}td.i{border:solid windowtext 1.0pt;border-bottom:none; padding:0cm .5pt 0cm .5pt}td.h{border-top:none;border-left:solid windowtext 1.0pt; border-bottom:none;border-right:solid windowtext 1.0pt;padding:0cm .5pt 0cm .5pt} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .f{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/

RNS Number : 1349C

Barclays PLC

08 June 2023

FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the $0.001 ordinary shares
dealings being disclosed relate (Note 2)
Date of dealing 07 Jun 2023
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Class of relevant security : $0.001 ordinary shares Long Short
Number (%) Number (%)
(1) Relevant securities 1,071,594 0.47% 676,045 0.30%
(2) Derivatives (other than options) 140,756 0.06% 98,064 0.04%
(3) Options and agreements to purchase/sell 1,420,000 0.62% 936,400 0.41%
TOTAL: 2,632,350 1.15% 1,710,509 0.75%
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3))
Class of relevant security : Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
TOTAL:
3. DEALINGS (Note 4)
(a) Purchases and sales
Class of relevant Security Purchase/sale Number of relevant securities Price per unit(Note 5)
$0.001 ordinary shares Purchase 4 99.9700 USD
$0.001 ordinary shares Purchase 12 99.6200 USD
$0.001 ordinary shares Purchase 100 99.7700 USD
$0.001 ordinary shares Purchase 183 99.6721 USD
$0.001 ordinary shares Purchase 208 100.0011 USD
$0.001 ordinary shares Purchase 591 99.7697 USD
$0.001 ordinary shares Purchase 625 99.7944 USD
$0.001 ordinary shares Purchase 1,604 99.8086 USD
$0.001 ordinary shares Purchase 2,073 99.6980 USD
$0.001 ordinary shares Purchase 3,349 99.4495 USD
$0.001 ordinary shares Purchase 3,430 99.7522 USD
$0.001 ordinary shares Purchase 3,538 99.6777 USD
$0.001 ordinary shares Purchase 3,819 99.7583 USD
$0.001 ordinary shares Purchase 5,912 99.4400 USD
$0.001 ordinary shares Purchase 9,526 99.6036 USD
$0.001 ordinary shares Purchase 18,131 99.5307 USD
$0.001 ordinary shares Sale 4 99.9700 USD
$0.001 ordinary shares Sale 15 99.8266 USD
$0.001 ordinary shares Sale 47 99.8600 USD
$0.001 ordinary shares Sale 100 99.9350 USD
$0.001 ordinary shares Sale 100 99.4100 USD
$0.001 ordinary shares Sale 200 100.0100 USD
$0.001 ordinary shares Sale 384 99.8183 USD
$0.001 ordinary shares Sale 854 99.7719 USD
$0.001 ordinary shares Sale 1,088 99.5147 USD
$0.001 ordinary shares Sale 1,317 99.6680 USD
$0.001 ordinary shares Sale 1,887 99.6843 USD
$0.001 ordinary shares Sale 1,932 99.8305 USD
$0.001 ordinary shares Sale 2,865 99.7536 USD
$0.001 ordinary shares Sale 8,391 99.6137 USD
$0.001 ordinary shares Sale 8,736 99.4400 USD
$0.001 ordinary shares Sale 24,224 99.5785 USD
(b) Derivatives transactions (other than options transactions)
Product name Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit(Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Class of Product name Writing, selling, Number of securities Exercise price Type Expiry date Option money
relevant security purchasing, to which the option paid/received
varying etc. relates (Note 7) per unit (Note 5)
(ii) Exercising
Product name Number of Exercise price per
securities unit (Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated
NONE
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure: 08 Jun 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)OPEN POSITIONS
Class of Product Description Writing, selling, Number of securities Exercise price Type Expiry date
relevant security purchasing, to which the option per unit
varying etc. relates
$0.001 ordinary shares Put Options Written 495,500 100.0000 American 16 Jun 2023
$0.001 ordinary shares Put Options Written 28,800 95.0000 American 21 Jul 2023
$0.001 ordinary shares Call Options Written -10,600 105.0000 American 18 Aug 2023
$0.001 ordinary shares Put Options Written 2,000 85.0000 American 21 Jul 2023
$0.001 ordinary shares Put Options Purchased -250,000 80.0000 American 16 Jun 2023
$0.001 ordinary shares Put Options Written 10,200 80.0000 American 18 Aug 2023
$0.001 ordinary shares Put Options Written 247,500 105.0000 American 16 Jun 2023
$0.001 ordinary shares Call Options Written -2,000 100.0000 American 21 Jul 2023
$0.001 ordinary shares Call Options Written -2,600 100.0000 American 18 Aug 2023
$0.001 ordinary shares Put Options Written 400,000 100.0000 American 18 Aug 2023
$0.001 ordinary shares Put Options Written 74,000 90.0000 American 15 Sep 2023
$0.001 ordinary shares Put Options Purchased -544,200 80.0000 American 18 Aug 2023
$0.001 ordinary shares Put Options Written 162,000 105.0000 American 21 Jul 2023
$0.001 ordinary shares Call Options Written -10,000 105.0000 American 16 Jun 2023
$0.001 ordinary shares Put Options Purchased -106,800 90.0000 American 21 Jul 2023
$0.001 ordinary shares Put Options Purchased -10,200 100.0000 American 18 Aug 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPKZGGVGRDGFZM